AstraZeneca plc (ADR) (NYSE:AZN)

CAPS Rating: 5 out of 5

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Recs

0
Player Avatar d0w0kelley (< 20) Submitted: 8/28/2011 12:27:40 AM : Outperform Start Price: $44.54 AZN Score: -17.92

Large Cap stock trading above their 14-day SMA

Featured Broker Partners


Advertisement